Peter C DeMuth

4PUBLICATIONS
14CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 29, 2026
Lymph node-targeted DNA engages TBK1/IFN-I-driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs.

|Jan 25, 2024
Lymph Node-Targeted Vaccine Boosting of TCR T-cell Therapy Enhances Antitumor Function and Eradicates Solid Tumors.

Dylan J Drakes, Abdulraouf M Abbas, Jacqueline Shields

|Oct 28, 2022
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates.

Lochana M Seenappa, Aniela Jakubowski, Martin P Steinbuck

|Feb 06, 2021
A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.

Martin P Steinbuck, Lochana M Seenappa, Aniela Jakubowski

Pageof 1

Frequent Collaborators

4 joint publications

Martin P Steinbuck

4 joint publications

Christopher M Haqq

3 joint publications

Lochana M Seenappa

3 joint publications

Aniela Jakubowski